drugset / Trial / NCT01482117

The Effect of Genetic Polymorphism on Interactions of Clopidogrel and Cilostazol in Healthy Volunteers

NCT01482117

Completed 28 enrolled Inje University
RandomizedCrossoverOpen-labelHealth-services research

Summary

The aim of this study is to investigate the effects of genetic polymorphisms on pharmacokinetic and pharmacodynamic interactions of clopidogrel and cilostazol in Korean healthy adult volunteers.

Timeline

Start
2011-11
Primary completion
2012-01
Completion
2012-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cilostazol Small molecule 100 mg Oral
Comparator Clopidogrel Small molecule 300 mg Oral

Indications

No indication recorded.